Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early development of cyclin dependent kinase modulators.

K K Roy1, E A Sausville

  • 1Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Insstitute, 10 center Drive, Building no 10, Room no 6N, Bethesda, MD-20892-5680, USA. kr91w@nih.gov

Current Pharmaceutical Design
|September 20, 2001
PubMed
Summary

Protein kinases, especially cyclin-dependent kinases (CDKs), are key targets for cancer drug discovery. Modulating CDK activity offers therapeutic potential for various proliferative disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Telemedicine: The New Vanguard in Gynecological Care.

Cureus·2025
Same author

A Randomized Controlled Trial Comparing the Efficacy of Bupivacaine Injection in Vaginal Vault and Paracervical Region Versus Vaginal Vault Infiltration with Bupivacaine After Total Laparoscopic Hysterectomy.

Journal of obstetrics and gynaecology of India·2025
Same author

The Effect of Salpingectomy on Ovarian Reserve Using Two Different Electrosurgical Instruments: Ultrasonic Shears Versus Bipolar Electrocautery.

Cureus·2024
Same author

Exploring the Role of Levonorgestrel Intrauterine System (LNG-IUS) as a Method of Emergency Contraception (EC).

Cureus·2023
Same author

Gynaecological Laparoscopic Surgeries in the Omicron Era: Improvising the Management Skills After Lessons Learnt From the Delta Wave.

Cureus·2022
Same author

Role of Incontinence Severity Index in Evaluating Severity and Impact of Treatment Of Stress Urinary Incontinence.

Journal of mid-life health·2022

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Protein kinases, particularly cyclin-dependent kinases (CDKs), regulate cell division and are frequently dysregulated in various cancers.
  • Aberrant CDK activity is implicated in proliferative disorders such as cancer, graft stenosis, and autoimmune diseases, making them attractive therapeutic targets.

Purpose of the Study:

  • To explore the potential of small molecule modulators targeting the ATP binding cleft of protein kinases, focusing on CDKs.
  • To review current strategies and emerging drug candidates for modulating aberrant CDK activity in cancer therapy.

Main Methods:

  • Screening of chemical compounds to identify modulators of CDK activity.
  • Review of existing and investigational small molecule inhibitors, including flavopiridol, UCN-01, flavopiridol analogs, indirubins, paullones, and purine-based inhibitors.

Related Experiment Videos

Main Results:

  • Small molecule modulators can inhibit kinase activity or influence cell cycle checkpoint functions.
  • Several classes of CDK inhibitors, including flavopiridol and UCN-01, are in early clinical trials.

Conclusions:

  • Targeting protein kinases, especially CDKs, represents a significant opportunity for developing novel therapeutics for cancer and other proliferative diseases.
  • The development of selective CDK modulators is crucial for effective cancer therapy and managing related disorders.